Phase 2 Study of Pevonedistat + Azacitidine Versus Azacitidine in Patients With Higher-risk Myelodysplastic Syndromes/chronic Myelomonocytic Leukemia or Low-blast Acute Myelogenous Leukemia (nct02610777)
Year: 2020
Type: article
Authors: L. Adès, J. Watts, A. Radinoff, M.A. Sangerman, M. Cerrano, P.F. Lopez, J. Zeidner, M.D. Campelo, C. Graux, J. Liesveld, D. Selleslag, N. Tzvetkov, R.J. Fram, D. Zhao, J. Bell, S. Friedlander, D.V. Faller, M.A. Sekeres
Institutions: Hôpital Saint-Louis, University of Miami, Sylvester Comprehensive Cancer Center, University Hospital St. Ivan Rilski, Institut d'Investigació Biomédica de Bellvitge, Institut Català d'Oncologia, University of Turin, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center, Universidad de Salamanca, Instituto de Investigación Biomédica de Salamanca, Centro de Investigación del Cáncer, Centro de Investigación Biomédica en Red de Cáncer, Instituto de Biología Molecular y Celular del Cáncer de Salamanca, UCLouvain, University of Rochester Medicine, University of Rochester, AZ Sint-Jan, University Hospital Dr. Georgi Stranski, Takeda Oncology (United States), Cleveland Clinic
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W3095139816